drugset / Trial / NCT00296335

Trial of Adjuvant Chemotherapy for Gastric Cancer

NCT00296335

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a phase III randomized study designed to evaluate the efficacy of mitomycin, doxifluridine, and cisplatin compared to mitomycin and doxifluridine.

Timeline

Start
2002-02
Primary completion
2007-11
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 60 mg/m2 Intravenous
Comparator doxifluridine Small molecule 460 mg/m2 Oral
Comparator doxifluridine Small molecule 600 mg/m2 Oral
Comparator Mitomycin C Other / unclassified 20 mg/m2 Intravenous